These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 35241150)

  • 41. Fibroblast activation protein-α in tumor cells promotes colorectal cancer angiogenesis via the Akt and ERK signaling pathways.
    Cao F; Wang S; Wang H; Tang W
    Mol Med Rep; 2018 Feb; 17(2):2593-2599. PubMed ID: 29207091
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of myeloid-derived chemokine CCL5/RANTES at an early stage of atherosclerosis.
    Jongstra-Bilen J; Tai K; Althagafi MG; Siu A; Scipione CA; Karim S; Polenz CK; Ikeda J; Hyduk SJ; Cybulsky MI
    J Mol Cell Cardiol; 2021 Jul; 156():69-78. PubMed ID: 33781821
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19.
    Ren J; Ding L; Zhang D; Shi G; Xu Q; Shen S; Wang Y; Wang T; Hou Y
    Theranostics; 2018; 8(14):3932-3948. PubMed ID: 30083271
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CCL5-deficiency enhances intratumoral infiltration of CD8
    Zhang S; Zhong M; Wang C; Xu Y; Gao WQ; Zhang Y
    Cell Death Dis; 2018 Jul; 9(7):766. PubMed ID: 29991744
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CCL5-CCR5 interactions modulate metabolic events during tumor onset to promote tumorigenesis.
    Gao D; Cazares LH; Fish EN
    BMC Cancer; 2017 Dec; 17(1):834. PubMed ID: 29216863
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth.
    Schlecker E; Stojanovic A; Eisen C; Quack C; Falk CS; Umansky V; Cerwenka A
    J Immunol; 2012 Dec; 189(12):5602-11. PubMed ID: 23152559
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CCL5-dependent mast cell infiltration into the tumor microenvironment in clear cell renal cell carcinoma patients.
    Liu T; Xia Q; Zhang H; Wang Z; Yang W; Gu X; Hou T; Chen Y; Pei X; Zhu G; He D; Li L; Xu S
    Aging (Albany NY); 2020 Nov; 12(21):21809-21836. PubMed ID: 33177244
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The CCL5/CCR5 Chemotactic Pathway Promotes Perineural Invasion in Salivary Adenoid Cystic Carcinoma.
    Gao T; Shen Z; Ma C; Li Y; Kang X; Sun M
    J Oral Maxillofac Surg; 2018 Aug; 76(8):1708-1718. PubMed ID: 29549020
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The potential to target CCL5/CCR5 in breast cancer.
    Velasco-Velázquez M; Xolalpa W; Pestell RG
    Expert Opin Ther Targets; 2014 Nov; 18(11):1265-75. PubMed ID: 25256399
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CCL5/CCR5 axis promotes the motility of human oral cancer cells.
    Chuang JY; Yang WH; Chen HT; Huang CY; Tan TW; Lin YT; Hsu CJ; Fong YC; Tang CH
    J Cell Physiol; 2009 Aug; 220(2):418-26. PubMed ID: 19334035
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CCR5/CCL5 axis interaction promotes migratory and invasiveness of pancreatic cancer cells.
    Singh SK; Mishra MK; Eltoum IA; Bae S; Lillard JW; Singh R
    Sci Rep; 2018 Jan; 8(1):1323. PubMed ID: 29358632
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TSG-6 promotes Cancer Cell aggressiveness in a CD44-Dependent Manner and Reprograms Normal Fibroblasts to create a Pro-metastatic Microenvironment in Colorectal Cancer.
    Liu B; Liu T; Liu Y; Feng X; Jiang X; Long J; Ye S; Chen D; Wang J; Yang Z
    Int J Biol Sci; 2022; 18(4):1677-1694. PubMed ID: 35280699
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CCL5-armed oncolytic virus augments CCR5-engineered NK cell infiltration and antitumor efficiency.
    Li F; Sheng Y; Hou W; Sampath P; Byrd D; Thorne S; Zhang Y
    J Immunother Cancer; 2020 Feb; 8(1):. PubMed ID: 32098828
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients.
    Halama N; Zoernig I; Berthel A; Kahlert C; Klupp F; Suarez-Carmona M; Suetterlin T; Brand K; Krauss J; Lasitschka F; Lerchl T; Luckner-Minden C; Ulrich A; Koch M; Weitz J; Schneider M; Buechler MW; Zitvogel L; Herrmann T; Benner A; Kunz C; Luecke S; Springfeld C; Grabe N; Falk CS; Jaeger D
    Cancer Cell; 2016 Apr; 29(4):587-601. PubMed ID: 27070705
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pivotal role of the CCL5/CCR5 interaction for recruitment of endothelial progenitor cells in mouse wound healing.
    Ishida Y; Kimura A; Kuninaka Y; Inui M; Matsushima K; Mukaida N; Kondo T
    J Clin Invest; 2012 Feb; 122(2):711-21. PubMed ID: 22214846
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CC chemokine receptor 5: the interface of host immunity and cancer.
    de Oliveira CE; Oda JM; Losi Guembarovski R; de Oliveira KB; Ariza CB; Neto JS; Banin Hirata BK; Watanabe MA
    Dis Markers; 2014; 2014():126954. PubMed ID: 24591756
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protein kinase Ds promote tumor angiogenesis through mast cell recruitment and expression of angiogenic factors in prostate cancer microenvironment.
    Xu W; Qian J; Zeng F; Li S; Guo W; Chen L; Li G; Zhang Z; Wang QJ; Deng F
    J Exp Clin Cancer Res; 2019 Mar; 38(1):114. PubMed ID: 30841931
    [TBL] [Abstract][Full Text] [Related]  

  • 58. WNT4 secreted by tumor tissues promotes tumor progression in colorectal cancer by activation of the Wnt/β-catenin signalling pathway.
    Yang D; Li Q; Shang R; Yao L; Wu L; Zhang M; Zhang L; Xu M; Lu Z; Zhou J; Huang L; Huang X; Cheng D; Yang Y; Yu H
    J Exp Clin Cancer Res; 2020 Nov; 39(1):251. PubMed ID: 33222684
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CCL5 neutralization restricts cancer growth and potentiates the targeting of PDGFRβ in colorectal carcinoma.
    Cambien B; Richard-Fiardo P; Karimdjee BF; Martini V; Ferrua B; Pitard B; Schmid-Antomarchi H; Schmid-Alliana A
    PLoS One; 2011; 6(12):e28842. PubMed ID: 22205974
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Autocrine WNT2 signaling in fibroblasts promotes colorectal cancer progression.
    Kramer N; Schmöllerl J; Unger C; Nivarthi H; Rudisch A; Unterleuthner D; Scherzer M; Riedl A; Artaker M; Crncec I; Lenhardt D; Schwarz T; Prieler B; Han X; Hengstschläger M; Schüler J; Eferl R; Moriggl R; Sommergruber W; Dolznig H
    Oncogene; 2017 Sep; 36(39):5460-5472. PubMed ID: 28553956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.